

Compact for Safe Cosmetics
|
Animal Testing Policy |


Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to one or more ingredients in this product -- not the product itself -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
Ingredients in this product are linked to: | |
![]() | Cancer |
![]() | Developmental/reproductive toxicity |
![]() | Violations, restrictions & warnings |
![]() | Allergies/immunotoxicity |
![]() | Other concerns for ingredients used in this product: Neurotoxicity, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Multiple, additive exposure sources, Contamination concerns |
Note: This product formulation was obtained from the FDA VCRD.
Ingredients from packaging: CYCLOPENTASILOXANE, TOCOPHEROL, DL-ALPHA, ASCORBYL PALMITATE, MICA, RED 7 LAKE (LABEL ABBREVIATION), PARAFFIN, POLYBUTENE, C11-12 ISOPARAFFIN, HYDROGENATED COTTONSEED OIL, CERESIN, OZOKERITE, MICROCRYSTALLINE WAX, SIMMONDSIA CHINENSIS (JOJOBA) SEED EXTRACT
| score | data gap | concerns | |
| HYDROGENATED COTTONSEED OIL | 8 | 75% | Contamination concerns (MERCURY, ARSENIC, LEAD, GOSSYPOL, PESTICIDES, PCBS) |
| D&C RED 7 LAKE RED 7 LAKE (LABEL ABBREVIATION) | 4 | 73% | Developmental/reproductive toxicity, Neurotoxicity |
| CYCLOPENTASILOXANE | 2 | 79% | Persistence and bioaccumulation |
| MICA | 3 | 75% | Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Occupational hazards |
| PARAFFIN | 2 | 80% | Organ system toxicity (non-reproductive), Occupational hazards |
| CERESIN | 0 | 93% | none identified |
| MICROCRYSTALLINE WAX (CERA MICROCRISTALLINA) | 1 | 93% | Organ system toxicity (non-reproductive) |
| POLYBUTENE | 1 | 92% | Organ system toxicity (non-reproductive) |
| OZOKERITE | 1 | 91% | none identified |
| TOCOPHEROL, DL-ALPHA | 1 | 90% | none identified |
| ASCORBYL PALMITATE (VITAMIN C PALMITATE) | 1 | 88% | none identified |
| C11-12 ISOPARAFFIN | 0 | 100% | none identified |
| SIMMONDSIA CHINENSIS (JOJOBA) SEED EXTRACT | 0 | 100% | none identified |
*This table includes all possible cancer concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show tumor formation at moderate doses | PARAFFIN, | |
| One or more animal studies show tumor formation at moderate doses | CYCLOPENTASILOXANE | |
| One or more in vitro tests on mammalian cells show positive mutation results | TOCOPHEROL, DL-ALPHA |
*This table includes all possible developmental/reproductive toxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Human nervous system toxicant - moderate evidence | D&C RED 7 LAKE |
*This table includes all possible violations, restrictions & warnings concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications | HYDROGENATED COTTONSEED OIL, D&C RED 7 LAKE |
*This table includes all possible neurotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show any effects at moderate doses | CYCLOPENTASILOXANE | |
| Strong evidence of human neurotoxicity | D&C RED 7 LAKE |
*This table includes all possible endocrine disruption concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show endocrine disruption at moderate doses | CYCLOPENTASILOXANE |
*This table includes all possible allergies/immunotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show gastrointestinal effects at moderate doses | MICA |
*This table includes all possible persistence and bioaccumulation concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Not suspected to be bioaccumulative | ASCORBYL PALMITATE (VITAMIN C PALMITATE) | |
| Not suspected to be persistent | TOCOPHEROL, DL-ALPHA, POLYBUTENE, HYDROGENATED COTTONSEED OIL, PARAFFIN, MICROCRYSTALLINE WAX (CERA MICROCRISTALLINA), D&C RED 7 LAKE | |
| Persistent, bioaccumulative in wildlife | CYCLOPENTASILOXANE | |
| Persistent, bioaccumulative in wildlife and humans | MICA |
*This table includes all possible organ system toxicity (non-reproductive) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | CYCLOPENTASILOXANE, ASCORBYL PALMITATE (VITAMIN C PALMITATE) | |
| One or more animal studies show sense organ effects at moderate doses (low dose studies may be unavailable for this ingredient) | products for use around the eyes, mouth, or lips | PARAFFIN, OZOKERITE |
| Possible human respiratory toxicant | MICA |
*This table includes all possible multiple, additive exposure sources concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Low human health concern based on exposure and toxicity | MICA, D&C RED 7 LAKE | |
| Moderate human health concern based on exposure and toxicity | POLYBUTENE, PARAFFIN, MICROCRYSTALLINE WAX (CERA MICROCRISTALLINA), CERESIN | |
| Designated as safe for general or specific, limited use in food | PARAFFIN, ASCORBYL PALMITATE (VITAMIN C PALMITATE) |
*This table includes all possible ecotoxicology concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Not known to be a wildlife or environmental toxin | POLYBUTENE, HYDROGENATED COTTONSEED OIL, PARAFFIN, MICROCRYSTALLINE WAX (CERA MICROCRISTALLINA), MICA, D&C RED 7 LAKE | |
| Wildlife and environmental toxicity | CYCLOPENTASILOXANE, ASCORBYL PALMITATE (VITAMIN C PALMITATE) |
*This table includes all possible irritation (skin, eyes, or lungs) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show skin irritation at moderate doses | PARAFFIN, OZOKERITE, CYCLOPENTASILOXANE |
*This table includes all possible data gaps concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | OZOKERITE, MICROCRYSTALLINE WAX (CERA MICROCRISTALLINA), CERESIN | |
| Not assessed for safety in cosmetics by industry panel | TOCOPHEROL, DL-ALPHA | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | ASCORBYL PALMITATE (VITAMIN C PALMITATE) | |
| Not assessed for safety in cosmetics by industry panel | C11-12 ISOPARAFFIN, CYCLOPENTASILOXANE, SIMMONDSIA CHINENSIS (JOJOBA) SEED EXTRACT | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | PARAFFIN, POLYBUTENE | |
| Pesticide inert of potential toxicological concern | POLYBUTENE |
No items in basket.
Add this product
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
Stay informed with email updates on toxics in everyday products and how they can affect your health.
It's true. EWG's researchers list the products and ingredients you should avoid in What Not to Buy.